Lecture

Rehabilitation Devices: Prosthetic Components and Business Strategies

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

MGT-555: Innovation & entrepreneurship in engineering

This course is a joint initiative between the School of Engineering and the College of Management to encourage and promote entrepreneurship and management skills, engineering design, hands-on experience, teamwork, and awareness of social and ethical implic ...

Description

This lecture covers the development and production of prosthetic components for physical rehabilitation, focusing on polypropylene technology, prosthetic feet, cost modeling, and field testing. It also discusses the business strategies, market potential, partnerships, and challenges faced in the industry.

Instructors (2)

Véronique Michaud

Background: 1994 Habilitation à diriger des recherches ( INPG, France) 1991 PhD in Materials Engineering ( MIT, USA) 1987 Ingénieur Civil des Mines ( Ecole des Mines de Paris, France) Activities: Since January 2018: Associate Dean of Engineering, in charge of Education June 2012-Dec.2017: Head of the Materials Science and Engineering Section Since April 2017: Associate Professor at EPFL 2009-2017 : Professeur Titulaire at EPFL 1997-2009: Researcher at EPFL 1994-1997 : Chef de Travaux au laboratoire MSS-MAT, Ecole Centrale Paris (France) 1991-1994 : Post-doctoral research associate, MIT (USA) Author of about 300 publications of which 140 in peer-reviewed journals

Thomas Alois Weber

Expertise

Credit collections - Decision making under risk - Economics (behavioral, environmental, theory) - Engineering economy - Investment criteria - Nonlinear systems - Optimal control - Risk - Sharing economy Expertise
Credit collections - Decision making under risk - Economics (behavioral, environmental, theory) - Engineering economy - Investment criteria - Nonlinear systems - Optimal control - Risk - Sharing economy Teaching & PhD PhD Students Ru Zhang Past EPFL PhD Students Maryam Razeghian Jah

Official source

Related concepts (32)

Diabetes

Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves.

Diabetes management

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance.

Partnership

A partnership is an arrangement where parties, known as business partners, agree to cooperate to advance their mutual interests. The partners in a partnership may be individuals, businesses, interest-based organizations, schools, governments or combinations. Organizations may partner to increase the likelihood of each achieving their mission and to amplify their reach. A partnership may result in issuing and holding equity or may be only governed by a contract.

Type 1 diabetes

Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that originates when cells that make insulin (beta cells) are destroyed by the immune system. Insulin is a hormone required for the cells to use blood sugar for energy and it helps regulate glucose levels in the bloodstream. Before treatment this results in high blood sugar levels in the body. The common symptoms of this elevated blood sugar are frequent urination, increased thirst, increased hunger, weight loss, and other serious complications.

Type 2 diabetes

Type 2 diabetes, formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. Symptoms may also include increased hunger, feeling tired, and sores (wounds) that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations.

Related lectures (64)

Strategic Marketing: Understanding Customer Needs and Value Proposition

Explores strategic marketing, customer needs, and value proposition for successful marketing strategies.

The Impact of Sugar Consumption

Explores the impact of sugar consumption on human health and well-being, from historical perspectives to modern-day challenges.

Drug Targets: Receptors, Enzymes, and Therapeutics

Explores drug targets, including receptors, enzymes, and therapeutics, covering pharmacodynamics, case studies on NSAIDs, diabetes, and drug toxicity.

Market Opportunity Navigator: Identifying Valuable Market Opportunities

Explores the Market Opportunity Navigator tool for identifying valuable market opportunities in various industries.

Smart Solutions for Health Monitoring